Brief: Abivax Provides Operational And Key Program Update
July 15 (Reuters) - Abivax SA ABVX.PA :
* ABIVAX PROVIDES OPERATIONAL AND KEY PROGRAM UPDATE
* ABIVAX PROVIDES OPERATIONAL AND KEY PROGRAM UPDATE
* ABIVAX SA: TOP-LINE RESULTS FROM ABTECT 8-WEEK INDUCTION
TRIAL
EXPECTED EARLY Q2 2025
* ABIVAX SA: CASH POSITION ALLOWS FOR RUNWAY INTO Q4 2025
* ABIVAX SA: SYLVIE GRÉGOIRE NAMED CHAIR OF ABIVAX'S BOARD
Source text for Eikon: ID:nGNX3KKk44
Further company coverage: ABVX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data